Clinical Trials Directory

Trials / Completed

CompletedNCT01903135

Prevalence of Obesity Hypoventilation Syndrome

Prevalence of Obesity Hypoventilation Syndrome in Subjects With Obesity Referred to Clinical (Medical Analysis) Laboratories for Regular Follow-up

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,004 (actual)
Sponsor
AGIR à Dom · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Rationale of the "BIO-OHS" study (Prevalence of Obesity Hypoventilation Syndrome): The overall prevalence of Obesity Hypoventilation Syndrome (OHS) has never been directly assessed in the general population. Actually, this prevalence has been assessed in patients referred to sleep clinics with a potential diagnosis of sleep-disordered breathing or in patients already diagnosed with sleep apnea. The purpose of this study is to determine the prevalence of Obesity Hypoventilation syndrome in obese patients referred to clinical laboratories for regular follow-up medical analysis.

Detailed description

No additional description

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood test analysis in the clinical labsfor specific measurement of plasmatic bicarbonate
PROCEDUREPneumologist consult to establish the diagnosis of OHScomplete respiratory check-up: Arterial blood gases analysis, spirometry, anthropometry, polygraphy or polysomnography. Medical history, previous treatments.

Timeline

Start date
2013-09-01
Primary completion
2015-02-01
Completion
2015-03-01
First posted
2013-07-19
Last updated
2017-02-01

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01903135. Inclusion in this directory is not an endorsement.